PepNovo

PepNovo performs de novo peptide sequencing from tandem mass spectrometry (MS/MS) data using probabilistic network modeling and likelihood ratio hypothesis testing to infer peptide sequences without relying on sequence databases.

Key Features:

• Probabilistic Network Modeling: Uses a probabilistic network that mirrors the chemical and physical rules governing peptide fragmentation to score candidate sequences from MS/MS spectra.
• Likelihood Ratio Hypothesis Test: Applies a likelihood ratio hypothesis test to assess whether observed spectral peaks are more likely generated by the fragmentation model or occur randomly.
• Chemical Fragmentation Integration: Integrates chemical and physical knowledge of peptide fragmentation into the scoring framework for more accurate peak interpretation.
• Performance on Ion Trap MS/MS: Demonstrated superior performance in comparative studies using ion trap MS/MS data relative to other de novo sequencing algorithms.

Scientific Applications:

• Proteomics peptide identification: Enables de novo identification of peptides from MS/MS spectra when database matches are unavailable or incomplete.
• Protein structure and sequence elucidation: Supports reconstruction of peptide sequences for downstream protein structural and functional analyses.
• Novel peptide discovery: Facilitates detection of peptides not present in existing sequence databases.
• Drug discovery and biomarker identification: Assists in identifying peptide candidates relevant to therapeutic discovery and biomarker research.
• Systems biology and pathway analysis: Provides peptide-level evidence that can inform pathway reconstruction and systems-level studies.

Methodology:

PepNovo employs a probabilistic network that encodes chemical and physical peptide fragmentation rules to generate and score sequence hypotheses from raw MS/MS spectra and refines these hypotheses using a likelihood ratio hypothesis test.